DermKnowledgeBASE: I-cell Disease

I-cell Disease

Semantic LIterature Summary Engine (SLISE)

( SLISE(Summary) - Drag this link to bookmarks bar for instant search)

Skin Deep - A Dermatology Blog

Loading........Please wait.

The text is the summary of recent articles on I-cell Disease at 75 thresold from National Library of Medicine (NLM). This information is subject to NCBI's Disclaimer and Copyright notice.


We report the progression of polysomnographic abnormalities in a Child with mucolipidosis II, demonstrated by worsening sleep-related hypoventilation, OSA, and sleep state fragmentation despite advancing PAP therapy [1]. Subsequent cardiac catheterization confirmed atresia of the left main coronary artery [2]. The patient underwent Cardiac Surgery with coronary artery bypass grafting of the left internal mammary artery to the left anterior descending coronary artery [3]. Repeat Cardiac catheterization revealed stenosis of the right Proximal coronary artery, raising concern for progressive coronary involvement [4]. These cargo molecules follow the secretory pathway, which is a vital part of cellular trafficking machinery in all eukaryotic Cells [5].

Here, we describe and illustrate various radiological-musculoskeletal manifestations of a rare case of mucolipidosis II who has been a survivor up to now, 20 years old [6]. Our case demonstrates several skeletal features of dysostosis multiplex [7]. It has remained unresolved, however, whether acid hydrolase binding is required for exit of the CI-MPR from the TGN [8]. These data show that there is no block in TGN exit of the CI-MPR in the absence of Man-6-P-modified acid hydrolases [9]. Most cargo is sorted within, and exits from, the trans-Golgi network (TGN) [10].

An 11-month-old Child presented with abnormal Head Shape, developmental delay and bent Bones [11]. We report here pathological findings of an autopsy case of mucolipidosis type ii [12]. The patient was an 8-year-old boy with mucolipidosis type ii and was complicated with hypertrophic cardiomyopathy [13]. He suddenly developed Progressive respiratory failure and finally died [14]. Niemann-Pick disease-C (NPC) was confirmed by fibroblasts study using filipin stain [15].

This disease is usually found to occur in individuals aged between 6 and 12 months, with a clinical phenotype resembling that of hurler syndrome and radiological findings resembling those of dysostosis multiplex [16]. At birth, the patient had characteristic features of ML II, and skeletal radiographs revealed dysostosis multiplex, similar to rickets [17]. The second patient had a much better outcome because of prompt diagnosis and was able to undergo Bone marrow transplant as a result [18]. This method describes the derivatization of oligosaccharides present in urine with phenyl-1-methylpyrazolone, which renders them hydrophobic, thus allowing desalting with Combi cleanup columns prior to injection [19]. A model system, consisting of cultured skin fibroblasts from patients with mucopolysaccharidoses (MPS), showed that their defective glycosaminoglycan catabolism could be corrected by factors derived from Cells of a different genotype [20].

For this reason we developed a mixed mode liquid chromatography tandem Mass spectrometry assay for the screening of the oligosaccharidoses which potentially mitigates many of the problems associated with thin layer chromatography [21]. MLII is an Autosomal recessive disease with a carrier rate estimated at 1/39 in Saguenay-Lac-Saint-Jean (SLSJ) (Quebec, Canada), which is the highest frequency documented worldwide [22]. The Bone disease in these patients is believed to be due to hyperparathyroidism [23]. Here, we applied the Qproteometrade mark GlycoArray kit to perform glycan analysis of heparanase, and compared the kit results with the more commonly used biochemical analyses [24]. Iodinated heparanase has been utilized to calculate binding affinity [25].

Here we report on an adolescent with progressive joint contractions and other signs of mucolipidosis II who survived to the age of 14 years [26]. The activities of serum alkaline phosphatase and parathyroid hormone were markedly elevated [27]. We conclude that early skeletal manifestation of mucolipidosis type ii is not clearly identified and that differentiation from congenital rickets or congenital hyperparathyroidism could be difficult [28]. These six patients exhibited a wide spectrum of clinical abnormalities, in particular shortened extremities: they included three patients with unknown causes of clinical symptoms, one patient with Sanfilippo disease, one of the seven patients with achondroplasia, and one with hypophosphotemic rickets [29]. The oligosaccharides were referenced against the internal standard, methyl lactose, to produce ratios for comparison with control samples [30].

This case expands the phenotypic spectrum of mucolipidosis type ii [31]. No useful markers were identified for krabbe disease, MPS II, Pompe disease, and Sandhoff disease [32].

References: 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ,

Press Refresh to fetch fresh content with references from pubmed. This content was cached on

comments powered by Disqus

|


This is an experimental application for healthcare professionals. The information presented here is not intended to diagnose, treat, cure or prevent any disease. Read disclaimer.

SkinHelpDesk.com - Evidence based skincare free

About Me

I have varied research interests ranging from eHealth, Health Information Exchange, Clinical Trials and Research, Contact Dermatitis, Bioinformatics, and Cosmetic Dermatology. I have work experience in Canada as an eHealth analyst, and in Dubai and India as a Specialist Dermatologist.

Address

Bell Raj Eapen
Hamilton, ON
Canada